TrialJournal for immunotherapy of cancer2025

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.

Jérémy Blanc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.